These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7799031)

  • 1. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
    Motzer RJ; Rodriguez E; Reuter VE; Bosl GJ; Mazumdar M; Chaganti RS
    J Clin Oncol; 1995 Jan; 13(1):274-82. PubMed ID: 7799031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorly differentiated carcinoma and germ cell tumors.
    Hainsworth JD; Greco FA
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1223-31. PubMed ID: 1663941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.
    Motzer RJ; Rodriguez E; Reuter VE; Samaniego F; Dmitrovsky E; Bajorin DF; Pfister DG; Parsa NZ; Chaganti RS; Bosl GJ
    J Natl Cancer Inst; 1991 Mar; 83(5):341-6. PubMed ID: 1847433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the i(12p) marker chromosome in germ cell tumors.
    Bosl GJ; Ilson DH; Rodriguez E; Motzer RJ; Reuter VE; Chaganti RS
    J Natl Cancer Inst; 1994 Mar; 86(5):349-55. PubMed ID: 8308927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site.
    Ilson DH; Motzer RJ; Rodriguez E; Chaganti RS; Bosl GJ
    Semin Oncol; 1993 Jun; 20(3):229-37. PubMed ID: 8503018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization.
    Schneider DT; Schuster AE; Fritsch MK; Calaminus G; Harms D; Göbel U; Perlman EJ
    Klin Padiatr; 2001; 213(4):204-11. PubMed ID: 11528555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors.
    Rodriguez E; Houldsworth J; Reuter VE; Meltzer P; Zhang J; Trent JM; Bosl GJ; Chaganti RS
    Genes Chromosomes Cancer; 1993 Dec; 8(4):230-6. PubMed ID: 7512366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.
    Motzer RJ; Amsterdam A; Prieto V; Sheinfeld J; Murty VV; Mazumdar M; Bosl GJ; Chaganti RS; Reuter VE
    J Urol; 1998 Jan; 159(1):133-8. PubMed ID: 9400455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization.
    Suijkerbuijk RF; Sinke RJ; Meloni AM; Parrington JM; van Echten J; de Jong B; Oosterhuis JW; Sandberg AA; Geurts van Kessel A
    Cancer Genet Cytogenet; 1993 Oct; 70(2):85-93. PubMed ID: 8242603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
    Greco FA; Johnson DH; Hainsworth JD
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):14-8. PubMed ID: 1492223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
    Christodoulou J; Schoch C; Schnittger S; Haferlach T
    Ann Hematol; 2004 Jun; 83(6):386-9. PubMed ID: 14615911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of chromosome aberrations in testicular germ cell tumor cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses.
    Summersgill BM; Jafer O; Wang R; Goker H; Niculescu-Duvaz I; Huddart R; Shipley J
    Cancer Genet Cytogenet; 2001 Jul; 128(2):120-9. PubMed ID: 11463450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases.
    Sung MT; Maclennan GT; Lopez-Beltran A; Zhang S; Montironi R; Cheng L
    Am J Surg Pathol; 2008 Jan; 32(1):146-55. PubMed ID: 18162782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors.
    Kernek KM; Brunelli M; Ulbright TM; Eble JN; Martignoni G; Zhang S; Michael H; Cummings OW; Cheng L
    Mod Pathol; 2004 Nov; 17(11):1309-13. PubMed ID: 15167939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
    Hainsworth JD; Johnson DH; Greco FA
    J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors.
    Bosl GJ; Dmitrovsky E; Reuter VE; Samaniego F; Rodriguez E; Geller NL; Chaganti RS
    J Natl Cancer Inst; 1989 Dec; 81(24):1874-8. PubMed ID: 2556586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic aspects of pediatric germ cell tumors].
    Stock C; Ambros IM; Strehl S; Zoubek A; Fink FM; Gadner H; Ambros PF
    Klin Padiatr; 1995; 207(4):235-41. PubMed ID: 7564160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
    Hainsworth JD; Erland JB; Kalman LA; Schreeder MT; Greco FA
    J Clin Oncol; 1997 Jun; 15(6):2385-93. PubMed ID: 9196154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.